WallStSmart

Braskem SA Class A (BAK)vsHuntsman Corporation (HUN)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Braskem SA Class A generates 1097% more annual revenue ($70.60B vs $5.90B). HUN leads profitability with a -3.0% profit margin vs -7.8%. BAK appears more attractively valued with a PEG of 1.46. HUN earns a higher WallStSmart Score of 55/100 (C).

BAK

Buy

52

out of 100

Grade: C-

Growth: 6.7Profit: 4.5Value: 5.3Quality: 4.5
Piotroski: 3/9Altman Z: 0.13

HUN

Buy

55

out of 100

Grade: C

Growth: 5.3Profit: 2.5Value: 3.7Quality: 4.5
Piotroski: 1/9Altman Z: 1.64
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BAK.

HUNSignificantly Overvalued (-18.9%)

Margin of Safety

-18.9%

Fair Value

$11.82

Current Price

$8.90

$2.92 premium

UndervaluedFair: $11.82Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BAK3 strengths · Avg: 9.3/10
EPS GrowthGrowth
107.2%10/10

Earnings expanding 107.2% YoY

Debt/EquityHealth
-5.4310/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
21.6%8/10

Revenue surging 21.6% year-over-year

HUN2 strengths · Avg: 9.0/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

EPS GrowthGrowth
20.6%8/10

Earnings expanding 20.6% YoY

Areas to Watch

BAK4 concerns · Avg: 2.5/10
Market CapQuality
$377.34M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-549.0%2/10

ROE of -549.0% — below average capital efficiency

Free Cash FlowQuality
$-535.00M2/10

Negative free cash flow — burning cash

HUN4 concerns · Avg: 3.5/10
PEG RatioValuation
2.224/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.644/10

Distress zone — elevated risk

Market CapQuality
$1.59B3/10

Smaller company, higher risk/reward

Operating MarginProfitability
1.7%3/10

Operating margin of 1.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : BAK

The strongest argument for BAK centers on EPS Growth, Debt/Equity, Revenue Growth. Revenue growth of 21.6% demonstrates continued momentum. PEG of 1.46 suggests the stock is reasonably priced for its growth.

Bull Case : HUN

The strongest argument for HUN centers on Price/Book, EPS Growth. Revenue growth of 14.1% demonstrates continued momentum.

Bear Case : BAK

The primary concerns for BAK are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : HUN

The primary concerns for HUN are PEG Ratio, Altman Z-Score, Market Cap.

Key Dynamics to Monitor

BAK profiles as a growth stock while HUN is a turnaround play — different risk/reward profiles.

HUN carries more volatility with a beta of 0.71 — expect wider price swings.

BAK is growing revenue faster at 21.6% — sustainability is the question.

HUN generates stronger free cash flow (-90M), providing more financial flexibility.

Bottom Line

HUN scores higher overall (55/100 vs 52/100) and 14.1% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Braskem SA Class A

BASIC MATERIALS · CHEMICALS · USA

Braskem SA produces and markets thermoplastic resins. The company is headquartered in Camaari, Brazil.

Huntsman Corporation

BASIC MATERIALS · CHEMICALS · USA

Huntsman Corporation manufactures and sells differentiated organic chemicals globally. The company is headquartered in The Woodlands, Texas.

Visit Website →

Want to dig deeper into these stocks?